Evonik is reorganizing its business for high-performance polymers within the polyamide group. The specialty chemicals company has already begun construction of a new polyamide 12 (PA 12) facility complex and is expanding its production of transparent polyamides at the Marl Chemical Park. As part of the reorganization process, the company will withdraw entirely from the polyphthalamide (PPA) business at the Witten site.
Essen/Germany — With the reorganization of their polyamide business, Evonik intends to concentrate their production and innovative strengths on specialty materials for promising applications in markets such as lightweight construction, additive manufacturing, and composites.
Evonik’s roughly $ 448 million investment in Germany will increase the company’s overall capacity for PA 12 by over 50 %. The project will complement existing PA 12 production at the Marl Chemical Park in the state of North Rhine-Westphalia with additional plants for the polymer and its precursors. The facility complex is scheduled to go on stream in the first half of 2021.
At the same time, the company will also be expanding production of transparent polyamides in Marl. Production expansion is slated for completion in the first quarter of 2020. The change will double the specialty chemicals company’s overall capacity for the high-performance material.
In another step in the process of reorganizing its polyamide business, the group will be discontinuing the production and sale of polyphthalamide at its Witten site by the end of the first quarter of 2020. The manufacturer will transfer employees from the PPA plant to its Marl site, where they will work at the new PA 12 production plant.
Biobased polymers from the Terra series remain in the business portfolio and will continue to complement Evonik’s now reorganized range of high-performance polymers.